Table 1.

Baseline patient demographic and clinical data.

Patient number	Age/Sex	CT collimation (mm)	Tumor pathology	Tumor location	Treatment
1	43/M	2.5 mm	ACC	Lacrimal gland	Exenteration
2	43/F	2.5 mm	ACC	Lacrimal gland	Exenteration
3*	47/F	1.25 mm	ACC	Lacrimal gland	Exenteration
4	43/F	5.0 mm	ACC	Lacrimal gland	Exenteration
5	69/F	1.25 mm	ACC	Lacrimal gland	Exenteration
6	24/F	1.25 mm	ACC	Lacrimal gland	Resection
7	29/M	1.25 mm	ACC	Lacrimal gland	Exenteration
8	36/M	1.25 mm	ACC	Lacrimal gland	Exenteration
9	17/M	1.25 mm	Carcinoma ex-pleomorphic adenoma	Lacrimal gland	Exenteration
10	25/F	1.25 mm	Pleomorphic adenoma	Lacrimal gland	Resection
11	57/M	1.25 mm	ACC	Lacrimal gland/sac	Exenteration
12	53/F	1.25 mm	Inverted papilloma	Lacrimal sac	Resection
13	51/M	1.25 mm	Synovial sarcoma	Intraconal	Exenteration
14	56/M	1.25 mm	Invasive basal cell carcinoma	Periorbital/infraorbital nerve	Chemoradiation
15	80/F	1.25 mm	Basaloid squamous carcinoma	Medial canthus	Exenteration
16	67/F	5 mm	Invasive squamous carcinoma	Medial canthus	Exenteration
17	59/M	2.5 mm	Neuroendocrine carcinoma	Intraconal	Exenteration
18	51/M	1.25 mm	Invasive squamous carcinoma	Medial orbit/sinonasal	Resection
19	46/M	1.25 mm	Neuroendocrine carcinoma	Medial orbit/sinonasal	Chemoradiation
20	46/M	1.25 mm	Pseudotumor**	Orbital apex	Steroids

ACC: adenoid cystic carcinoma; NA: not applicable.

*No intravenous contrast.

**Responded to treatment with steroids.